Form D · Biotechnology
ExcaliVir, Inc.
Doylestown, PA · CIK 0001685433
Offering snapshot reported Sep 26, 2016 · SEC filing
- Reported sold
- $734K Offering amount: $2.24M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 13, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 26, 2016 | Initial | $733,883 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-271253
Source: Form D, filed Sep 26, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Poisel | Director |
| Joe Zack | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
130 Wagon Wheel Lane
Doylestown, PA, 18901
Doylestown, PA, 18901